Cite

HARVARD Citation

    Gattlen, C. et al. (n.d.). The Prembion® pre-biotic improves the impact of anti-CTLA4 immune checkpoint inhibitor in a murine model of malignant pleural mesothelioma. British journal of surgery. p. . [Online]. 
  
Back to record